Literature DB >> 3637201

Concentrations of glandular kallikrein in human nasal secretions increase during experimentally induced allergic rhinitis.

C R Baumgarten, R C Nichols, R M Naclerio, D Proud.   

Abstract

We have previously demonstrated that a mixture of bradykinin and lysylbradykinin is generated in nasal secretions during the immediate allergic response to allergen. The present studies were performed to determine whether glandular kallikrein plays a role in kinin formation during the allergic reaction. Allergic individuals (n = 7) and nonallergic controls (n = 7) were challenged intranasally with appropriate allergen, and nasal lavages obtained before and after challenge were assayed for immunoreactive glandular kallikrein as well as for histamine, kinins, and N-alpha-tosyl-L-arginine methyl esterase (TAME-esterase) activity. The increase in postchallenge immunoreactive glandular kallikrein levels above baseline was significantly greater (p less than 0.01) for the allergic group (16.3 +/- 14 ng/ml; means +/- SD) than for the nonallergic controls (1.0 +/- 1.9 ng/ml). Increased levels of immunoreactive glandular kallikrein correlated with increases in kinins, histamine, and TAME-esterase activity and with the onset of clinical symptoms. Characterization of immunoreactive glandular kallikrein purified from postchallenge lavages by immunoaffinity chromatography confirmed the identity of this material as an authentic glandular kallikrein on the basis of its inhibition by protease inhibitors and by monospecific antibody to tissue kallikrein, its chromatographic behavior on gel filtration, and its ability to generate lysylbradykinin from highly purified human low m.w. kininogen. The specific activity of this purified material, in terms of kinin generation from kininogen, was very similar to that for authentic glandular kallikrein, suggesting that most if not all of the immunoreactive material purified from nasal lavages represented active enzyme. Inhibition studies by using pooled postchallenge lavages suggest that the majority of the kinin generating activity in these samples was due to glandular kallikrein. We conclude, therefore, that glandular kallikrein is secreted during the allergic response and can contribute to the formation of the lysylbradykinin produced during the allergic reaction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3637201

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Leukocytic cell sources of airway tissue kallikrein.

Authors:  Isabel T Lauredo; Rosanna M Forteza; Yelena Botvinnikova; William M Abraham
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-12-05       Impact factor: 5.464

Review 2.  Bradykinin formation. Plasma and tissue pathways and cellular interactions.

Authors:  A P Kaplan; K Joseph; Y Shibayama; Y Nakazawa; B Ghebrehiwet; S Reddigari; M Silverberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

3.  Localization of immunoreactive tissue kallikrein in the seromucous glands of the human and guinea-pig respiratory tree.

Authors:  M T Poblete; G Garces; C D Figueroa; K D Bhoola
Journal:  Histochem J       Date:  1993-11

4.  Specificity of human tissue kallikrein towards substrates containing Phe-Phe pair of amino acids.

Authors:  D C Pimenta; J Chao; L Chao; M A Juliano; L Juliano
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

5.  Involvement of kinins in hyperresponsiveness induced by platelet activating factor in the human nasal airway.

Authors:  P J Turner; J W Dear; J C Foreman
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

6.  Human eosinophil-granule major basic protein and synthetic polycations induce airway hyperresponsiveness in vivo dependent on bradykinin generation.

Authors:  A J Coyle; S J Ackerman; R Burch; D Proud; C G Irvin
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

7.  Specificity of S'1 and S'2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P'1 and P'2 positions in design of inhibitors.

Authors:  Daniel C Pimenta; Sandro E Fogaça; Robson L Melo; Luiz Juliano; Maria A Juliano
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

8.  Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects.

Authors:  S C Christiansen; D Proud; C G Cochrane
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

Review 9.  The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance.

Authors:  Eleni Papakonstantinou; George Karakiulakis
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

Review 10.  The kinin system in rhinitis and asthma.

Authors:  D Proud
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.